Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
R. Tamisier (Grenoble, France), J. Richoux (Grenoble, France), S. Bailly (Grenoble, France), S. Baillieul (Grenoble, France), R. Guzun (Grenoble, France), M. Destors (Grenoble, France), J. Pépin (Grenoble, France). Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).. 2493

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS) Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010 Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA). Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020 Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS) Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA) Source: Sleep and Breathing Conference 2021 Year: 2021 Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005 Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP) Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems Source: Annual Congress 2010 - The upper airway and oral appliances Year: 2010 Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006 Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP) Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010 Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Does positional apnea influence optimum continuous positive airway pressure (CPAP) in obstructive sleep apnea (OSA)? Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005 Recent weight history in patients with obstructive sleep apnea syndrome (OSAS) prior to continuous positive airway pressure (CPAP) therapy Source: Eur Respir J 2006; 28: Suppl. 50, 648s Year: 2006 Effect of nCPAP on work performance (WP) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 725s Year: 2005 Positional obstructive sleep apnea (OSA) and automatic positive airway pressure (APAP) therapy Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA Year: 2012 Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Factors influencing the level of efficient pressure of continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea (OSAS) Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea Year: 2016 The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005